Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 12, 2020
Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi
Yuli L Hsieh, Andreas Jahn, Nicolas A Menzies, et al.
Lancet (London, England)
|
July 19, 2011
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
Erik J Schouten, Andreas Jahn, Dalitso Midiani, et al.
The Lancet. HIV
|
August 16, 2023
Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15-64 years: population-based HIV impact assessments, 2015-16 and 2020-21
Danielle Payne, Nellie Wadonda-Kabondo, Alice Wang, et al.
The Lancet. Global Health
|
September 20, 2024
Assessing the effect of health system resources on HIV and tuberculosis programmes in Malawi: a modelling study
Tara D Mangal, Sakshi Mohan, Timothy Colbourn, et al.
Human Mutation
|
July 11, 2012
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities
Florian Mittag, Finja Büchel, Mohamad Saad, et al.
Antiviral Therapy
|
August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi
George Bello, Matthew Kagoli, Sikhona Chipeta, et al.
Plos One
|
October 27, 2025
"I just thought I was lucky to be protected from HIV:" Qualitative evaluation of barriers and facilitators of pre-exposure prophylaxis use for adolescent girls and young women at higher risk of HIV acquisition in Lilongwe, Malawi
Mallory Michalak, Odala Sande, Sam Phiri, et al.
The Lancet. HIV
|
December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
Andrew N Phillips, Francois Venter, Diane Havlir, et al.
Plos Medicine
|
February 15, 2020
Emerging priorities for HIV service delivery
Nathan Ford, Elvin Geng, Tom Ellman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program
Nellie Wadonda-Kabondo, Diane Bennett, Joep J van Oosterhout, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 12, 2020
Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi
Yuli L Hsieh, Andreas Jahn, Nicolas A Menzies, et al.
Lancet (London, England)
|
July 19, 2011
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
Erik J Schouten, Andreas Jahn, Dalitso Midiani, et al.
The Lancet. HIV
|
August 16, 2023
Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15-64 years: population-based HIV impact assessments, 2015-16 and 2020-21
Danielle Payne, Nellie Wadonda-Kabondo, Alice Wang, et al.
The Lancet. Global Health
|
September 20, 2024
Assessing the effect of health system resources on HIV and tuberculosis programmes in Malawi: a modelling study
Tara D Mangal, Sakshi Mohan, Timothy Colbourn, et al.
Human Mutation
|
July 11, 2012
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities
Florian Mittag, Finja Büchel, Mohamad Saad, et al.
Antiviral Therapy
|
August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi
George Bello, Matthew Kagoli, Sikhona Chipeta, et al.
Plos One
|
October 27, 2025
"I just thought I was lucky to be protected from HIV:" Qualitative evaluation of barriers and facilitators of pre-exposure prophylaxis use for adolescent girls and young women at higher risk of HIV acquisition in Lilongwe, Malawi
Mallory Michalak, Odala Sande, Sam Phiri, et al.
The Lancet. HIV
|
December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
Andrew N Phillips, Francois Venter, Diane Havlir, et al.
Plos Medicine
|
February 15, 2020
Emerging priorities for HIV service delivery
Nathan Ford, Elvin Geng, Tom Ellman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program
Nellie Wadonda-Kabondo, Diane Bennett, Joep J van Oosterhout, et al.
Page
of 16